Poging GOUD - Vrij
How a Chinese AI company worked around U.S. rules to access Nvidia’s top chips
Mint Ahmedabad
|November 14, 2025
In Indonesia, semiconductors covered by U.S. export controls are ready to help a Shanghai-based group
Indonesian telecom provider Indosat Ooredoo Hutchison sells computing power from a data center in Jakarta.
President Trump made clear earlier this month that he doesn’t want Nvidia selling its most advanced artificial-intelligence chips to China.
But inside a tall, windowless building in Indonesia’s capital, about 2,300 of those chips are ready to do work for a Chinese AI company.
A Wall Street Journal investigation traced how a chain of deals across several countries got the chips inside the data center, which is wedged between a private school and an upscale apartment complex. A company that arranged the transaction is a subsidiary of a Chinese business on an American trade blacklist.
Despite American rules intended to stop China from accessing the tech industry's most coveted hardware, there is no evidence to suggest the deals violated U.S. law.
Some former and current U.S. national-security officials say the U.S. should review deals such as the Jakarta one. Nvidia and other tech companies argue for fewer export controls, saying it is better to have the rest of the world hooked on American technology and financing American innovation.
The U.S. and China are in an arms race over AI, which can deliver military and economic advantages. America’s edge is that the world’s top AI chip company, Nvidia, is based in California. Since 2022, China has been barred from buying the most advanced U.S. semiconductors over national-security concerns.
Nvidia’s chief executive, Jensen Huang, recently said Nvidia’s market share in China has fallen to zero from 95% owing to U.S. export restrictions. But Chinese companies and organizations still use Nvidia products.
Dit verhaal komt uit de November 14, 2025-editie van Mint Ahmedabad.
Abonneer u op Magzter GOLD voor toegang tot duizenden zorgvuldig samengestelde premiumverhalen en meer dan 9000 tijdschriften en kranten.
Bent u al abonnee? Aanmelden
MEER VERHALEN VAN Mint Ahmedabad
Mint Ahmedabad
'If you're on trend, you are in trouble'
Patou creative head Guillaume Henry discusses the essence of couture and why simple is best
4 mins
December 13, 2025
Mint Ahmedabad
GST cuts, easing inflation drive rural demand revival
India’s rural economy expanded and recovered strongly in late 2025, with consumption, incomes and investment improving after a key tax reform and as inflation eased, a survey showed.
2 mins
December 13, 2025
Mint Ahmedabad
Chair man, of the bored
STREAM OF STORIES
3 mins
December 13, 2025
Mint Ahmedabad
Anju Dodiya creates disquieting worlds
Artist Anju Dodiya discusses the ideas, influences and inspiration behind her new solo show, 'The Geometry of Ash'
5 mins
December 13, 2025
Mint Ahmedabad
Bar hopping with Lounge
\"The things that make a cocktail really great are often very simple details—the frozen glass, the lemon twist—that transform two fingers of alcohol into an ice-glazed elixir,\" writes Alice Lascelles in her excellent guide to making cocktails at home, The Cocktail Edit.
1 mins
December 13, 2025
Mint Ahmedabad
New Delhi and France revise 1992 tax treaty
India and France have struck a deal to revise their 1992 treaty which will halve the tax on dividends paid by Indian units to French parents, potentially saving millions for companies with major operations in the South Asian nation, documents show.
1 min
December 13, 2025
Mint Ahmedabad
Ozempic debuts with a ₹2,200-a-week price tag
for chronic weight management, Novo Nordisk is positioning Ozempic as a treatment of type 2 diabetes with weight loss benefits, competing with Eli Lily’s Mounjaro that was launched in India in March.
1 mins
December 13, 2025
Mint Ahmedabad
How 'puri-aloo' and 'chaat' unite Lucknow
Whenever my friends want to eat puri-aloo, they invite themselves over to my home.
5 mins
December 13, 2025
Mint Ahmedabad
Novo Nordisk debuts Ozempic at ₹2,200 a week
Danish drugmaker Novo Nordisk on Friday launched its blockbuster diabetes drug Ozempic in India, with a starting price of ₹2,200 per week.
1 mins
December 13, 2025
Mint Ahmedabad
Govt’s insurance reform allows 100% FDI, composite licences
The government has paved the way for 100% foreign direct investment in the insurance sector, composite licences and easier capital requirements, among others sweeping reforms, as the Union cabinet cleared the enabling legislation, said two officials aware of the matter.
1 mins
December 13, 2025
Listen
Translate
Change font size
